<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Bras Pneumol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Bras Pneumol</journal-id>
      <journal-id journal-id-type="publisher-id">jbpneu</journal-id>
      <journal-title-group>
        <journal-title>Jornal Brasileiro de Pneumologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1806-3713</issn>
      <issn pub-type="epub">1806-3756</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Pneumologia e Tisiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26578141</article-id>
      <article-id pub-id-type="pmc">4635096</article-id>
      <article-id pub-id-type="doi">10.1590/S1806-37132015000000150</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter To The Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Idiopathic pleuroparenchymal fibroelastosis: incidental findings in a patient with suspected pneumonia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rea</surname>
            <given-names>Gaetano</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Poletti</surname>
            <given-names>Venerino</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Iadevaia</surname>
            <given-names>Carlo</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bocchino</surname>
            <given-names>Marialuisa</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mazzarella</surname>
            <given-names>Gennaro</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Dipartimento di Radiologia, Ospedale Monaldi di Napoli, Napoli, Italia</aff>
      <aff id="aff2"><label>2</label>Dipartimento di Pneumologia, Ospedale Morgagni-Pierantoni, Forl&#xEC;, Italia.</aff>
      <aff id="aff3"><label>3</label>Dipartimento di Scienze Cardio-toraciche e Respiratorie, Scuola di Medicina e Chirurgia, Seconda Universit&#xE0; degli Studi di Napoli, Napoli, Italia.</aff>
      <aff id="aff4"><label>4</label>Divisione di Medicina Respiratoria, Dipartimento di Medicina Clinica e Chirurgia, Scuola di Medicina e Chirurgia, Universit&#xE0; degli Studi di Napoli Federico II, Napoli, Italia</aff>
      <pub-date pub-type="epub-ppub">
        <season>Sep-Oct</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2015</year>
      </pub-date>
      <volume>41</volume>
      <issue>5</issue>
      <fpage>478</fpage>
      <lpage>479</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
        </license>
      </permissions>
      <counts>
        <fig-count count="2"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="5"/>
        <page-count count="2"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>TO THE EDITOR:</title>
      <p>Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is an uncommon disease of the pleura and lungs. In 2013, IPPFE was classified as a rare interstitial lung disease (ILD) in a joint American Thoracic Society/European Respiratory Society statement on the classification of the idiopathic interstitial pneumonias.<sup>(</sup>
<xref rid="B01" ref-type="bibr">1</xref>
<sup>)</sup> Characterized by fibrosis, together with thickening of the pleural and subpleural tissue (subpleural fibroelastosis), IPPFE predominantly affects the periphery of the upper lung lobes, with volume loss, as first described by Frankel et al. in 2004. <sup>(</sup>
<xref rid="B02" ref-type="bibr">2</xref>
<sup>)</sup> To date, no more than forty cases of IPPFE have been described in the literature in English. There is currently no consensus regarding the diagnostic criteria used in order to classify IPPFE, as well as regarding whether or not it represents a real, new, specific entity. Although the etiology is unknown, conditions associated with the disease include infections, bone marrow transplantation, autoimmunity, and possibly genetic predisposition. Clinically, patients with IPPFE usually present with chronic respiratory symptoms such as dyspnea and dry cough. The diagnosis of IPPFE is established on the basis of clinical, radiological, and histopathological findings. Chest HRCT scans show marked subpleural consolidations with irregular thickening; distortion, usually located in upper lung lobes ("pleural cap"); subpleural bronchiolectasis; reticular opacities; and, in some cases, mild honeycombing. These features are similar to those of other forms of idiopathic pulmonary fibrosis. However, in IPPFE, they are seen mainly in upper lobes, being rare or absent in the lower lobes.<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>,</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>)</sup> The histological characteristics of IPPFE are homogeneous subpleural fibrosis and abundant elastic fibers on elastic fiber stains.<sup>(</sup>
<xref rid="B05" ref-type="bibr">5</xref>
<sup>)</sup>
</p>
      <p>A 55-year-old nonsmoking female presented to her pulmonologist with fever (38&#xB0;C for six days), worsening of dyspnea under stress, and a productive cough. The patient stated that she had not been previously exposed to environmental allergens or asbestos. She further stated that she had not used any drugs and had not been previously exposed to environmental allergens, as well as that she had not been under treatment with chemotherapy or radiotherapy. She tested positive only for autoantibodies against endomysium; other serological tests were negative. Physical examination showed that, over a period of six months, she had lost weight (5 kg) and muscle mass. There was also a reduction in oxygen saturation (SaO<sub>2</sub> of 81% on room air). On auscultation, there were reduced breath sounds and mild bilateral rales in the upper lung fields. Heart rate and rhythm were normal. Her extremities were also normal, without digital clubbing. Pulmonary function tests showed normal FVC (96%) and normal FEV<sub>1</sub> (91%), although the DLCO was reduced (61%). An initial chest X-ray (not shown) revealed marked, irregular opacities in the subpleural region of the upper fields, with mild upper hilar retraction. Fiberoptic bronchoscopy with BAL was carried out, and neutrophils were found to account for 72% of the inflammatory cells (normal value, 1-2%). Microbiology tests were negative. To elucidate the chest X-ray and BAL findings, we performed chest HRCT. The HRCT scans showed peripheral foci of lung consolidation, with distortion and irregular pleuroparenchymal thickening, that was most evident in the subpleural regions of the upper lobes, accompanied by bronchiolectasis, mild interlobular septal thickening, and (in rare cases) microcystic subpleural changes (<xref ref-type="fig" rid="f01">Figure 1</xref>A). Scans of the lower lung fields (middle lobe and lingula) showed considerably fewer fibrotic changes, no distortion or other interstitial disease being observed in the apical and basal segments of the lower lobes (Figures 1B and 1C, respectively). These HRCT characteristics pose a diagnostic dilemma for the radiologist, who must make the differential diagnosis among IPPFE, sarcoidosis, and (albeit less likely) chronic hypersensitivity pneumonia. Therefore, we also performed a pleuroparenchymal frozen section biopsy in the upper lobes. Histopathological findings from elastic fiber staining revealed distortion and marked pleural thickening, with evidence of dense fibroelastotic tissue in the pleura and alveolar walls, together with sparse fibroblastic foci near the transition from the lung to the pleura (<xref ref-type="fig" rid="f01">Figure 1</xref>D). On the basis of the clinical and radiological data, a diagnosis of IPPFE was made. In conclusion, although there are specific HRCT features that are suggestive of IPPFE, the disease continues to be underdiagnosed, probably because there is still a significant lack of knowledge and awareness of this entity. A diagnosis of IPPFE should be considered in cases of pulmonary fibrosis that is located predominantly in the upper lobes. The differential diagnosis includes advanced hypersensitivity pneumonia, advanced sarcoidosis, advanced smoking-related ILD, asbestosis, connective tissue disease, radiation pneumonia, and drug-induced lung disease. The possibility of IPPFE should therefore be borne in mind when the radiological evidence is not consistent with other, more well-defined ILDs. It is recommended that surgical biopsy (using video-assisted thoracoscopic surgery)-or better yet frozen section biopsy-be performed in the affected area. A greater understanding of the etiology, risk factors, prognosis, and therapy related to IPPFE is needed in order to manage this disease in the future.</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>Chest HRCT and histology: A) HRCT scan showing marked subpleural thickening and irregular consolidations (black arrows), reticular opacities in the lung parenchyma at upper lobes, microcystic subpleural changes (white arrows), and bronchiolectasis; B) HRCT scan showing sparse fibrotic subpleural changes in the apical segments of the lower lung lobes, most pronounced on the right; C) HRCT scan showing near absence of fibrotic changes in the basal segments of the lower lung lobes; and D) histological section showing dense subpleural fibroelastotic tissue with an abrupt transition from pathological to normal lung parenchyma, containing a fibroblastic focus.</title></caption><graphic xlink:href="1806-3713-jbpneu-41-05-00478-gf01"/></fig>
</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Travis</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Costabel</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Hansell</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>King TE</surname>
              <given-names>Jr</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Nicholson</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
          <article-title>An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>2013</year>
          <volume>188</volume>
          <issue>6</issue>
          <fpage>733</fpage>
          <lpage>748</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1164/rccm.201308-1483ST">http://dx.doi.org/10.1164/rccm.201308-1483ST</ext-link>
          <pub-id pub-id-type="pmid">24032382</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frankel</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Cool</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>KK</given-names>
            </name>
          </person-group>
          <article-title>Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity</article-title>
          <source>Chest</source>
          <year>2004</year>
          <volume>126</volume>
          <issue>6</issue>
          <fpage>2007</fpage>
          <lpage>2013</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1378/chest.126.6.2007">http://dx.doi.org/10.1378/chest.126.6.2007</ext-link>
          <pub-id pub-id-type="pmid">15596706</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piciucchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tomassetti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Casoni</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sverzellati</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Carloni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dubini</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>High resolution CT and histological findings in idiopathic pleuroparenchymal fibroelastosis: features and differential diagnosis</article-title>
          <source>Respir Res</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>111</fpage>
          <lpage>111</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1465-9921-12-111">http://dx.doi.org/10.1186/1465-9921-12-111</ext-link>
          <pub-id pub-id-type="pmid">21861891</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Camus</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>von der Th&#xFC;sen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hansell</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Colby</surname>
              <given-names>TV</given-names>
            </name>
          </person-group>
          <article-title>Pleuroparenchymal fibroelastosis: one more walk on the wild side of drugs?</article-title>
          <source>Eur Respir J</source>
          <year>2014</year>
          <volume>44</volume>
          <issue>2</issue>
          <fpage>289</fpage>
          <lpage>296</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1183/09031936.00088414">http://dx.doi.org/10.1183/09031936.00088414</ext-link>
          <pub-id pub-id-type="pmid">25082907</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Becker</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Gil</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Padilla</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?</article-title>
          <source>Mod Pathol</source>
          <year>2008</year>
          <volume>21</volume>
          <issue>6</issue>
          <fpage>784</fpage>
          <lpage>787</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/modpathol.2008.56">http://dx.doi.org/10.1038/modpathol.2008.56</ext-link>
          <pub-id pub-id-type="pmid">18408658</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="S01" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Carta Ao Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Fibroelastose pleuroparenquimatosa idiop&#xE1;tica: achados incidentais em uma paciente com suspeita de pneumonia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rea</surname>
            <given-names>Gaetano</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Poletti</surname>
            <given-names>Venerino</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Iadevaia</surname>
            <given-names>Carlo</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bocchino</surname>
            <given-names>Marialuisa</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mazzarella</surname>
            <given-names>Gennaro</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">
<sup>3</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>Dipartimento di Radiologia, Ospedale Monaldi di Napoli, Napoli, Italia.</aff>
      <aff id="aff02"><label>2</label>Dipartimento di Pneumologia, Ospedale Morgagni-Pierantoni, Forl&#xEC;, Italia.</aff>
      <aff id="aff03"><label>3</label>Dipartimento di Scienze Cardio-toraciche e Respiratorie, Scuola di Medicina e Chirurgia, Seconda Universit&#xE0; degli Studi di Napoli, Napoli, Italia.</aff>
      <aff id="aff04"><label>4</label>Divisione di Medicina Respiratoria, Dipartimento di Medicina Clinica e Chirurgia, Scuola di Medicina e Chirurgia, Universit&#xE0; degli Studi di Napoli Federico II, Napoli, Italia.</aff>
    </front-stub>
    <body>
      <sec>
        <title>AO EDITOR:</title>
        <p>A fibroelastose pleuroparenquimatosa idiop&#xE1;tica (FEPPI) &#xE9; uma doen&#xE7;a rara que afeta a pleura e os pulm&#xF5;es. Em 2013, a FEPPI foi considerada uma doen&#xE7;a pulmonar intersticial (DPI) rara em uma declara&#xE7;&#xE3;o conjunta da <italic>American Thoracic Society</italic>/<italic>European Respiratory Society</italic> sobre a classifica&#xE7;&#xE3;o das pneumonias intersticiais idiop&#xE1;ticas.<sup>(</sup>
<xref rid="B01" ref-type="bibr">1</xref>
<sup>)</sup> Caracterizada por fibrose e espessamento do tecido pleural e subpleural (fibroelastose subpleural), a FEPPI afeta predominantemente a periferia dos lobos pulmonares superiores, com perda de volume, como inicialmente descreveram Frankel et al. em 2004.<sup>(</sup>
<xref rid="B02" ref-type="bibr">2</xref>
<sup>)</sup> At&#xE9; o momento, n&#xE3;o mais de quarenta casos de FEPPI foram descritos na literatura em ingl&#xEA;s. Atualmente, al&#xE9;m de n&#xE3;o haver consenso a respeito dos crit&#xE9;rios diagn&#xF3;sticos usados para classificar a FEPPI, n&#xE3;o se sabe se a doen&#xE7;a &#xE9; de fato uma entidade espec&#xED;fica nova. Embora a etiologia seja desconhecida, a FEPPI est&#xE1; relacionada com infec&#xE7;&#xF5;es, transplante de medula &#xF3;ssea, autoimunidade e, possivelmente, predisposi&#xE7;&#xE3;o gen&#xE9;tica. Clinicamente, pacientes com FEPPI geralmente apresentam sintomas respirat&#xF3;rios cr&#xF4;nicos como dispneia e tosse seca. O diagn&#xF3;stico de FEPPI baseia-se em achados cl&#xED;nicos, radiol&#xF3;gicos e histopatol&#xF3;gicos. A TCAR de t&#xF3;rax mostra consolida&#xE7;&#xF5;es subpleurais pronunciadas com espessamento irregular; distor&#xE7;&#xE3;o, geralmente nos lobos pulmonares superiores ("capa pleural"); bronquiolectasias subpleurais; opacidades reticulares e, em alguns casos, faveolamento leve. Essas caracter&#xED;sticas s&#xE3;o semelhantes &#xE0;s de outras formas de fibrose pulmonar idiop&#xE1;tica. No entanto, na FEPPI, elas s&#xE3;o vistas principalmente nos lobos superiores, e s&#xE3;o raras ou ausentes nos lobos inferiores.<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>,</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>)</sup> As caracter&#xED;sticas histol&#xF3;gicas da FEPPI s&#xE3;o fibrose subpleural homog&#xEA;nea e fibras el&#xE1;sticas abundantes (vistas por meio de t&#xE9;cnicas de colora&#xE7;&#xE3;o de fibras el&#xE1;sticas).<sup>(</sup>
<xref rid="B05" ref-type="bibr">5</xref>
<sup>)</sup>
</p>
        <p>Uma paciente n&#xE3;o fumante de 55 anos de idade procurou seu pneumologista com febre (38&#xB0;C durante seis dias), piora da dispneia sob estresse e tosse produtiva. A paciente disse que n&#xE3;o havia sido exposta a al&#xE9;rgenos ambientais ou amianto. Disse ainda que n&#xE3;o havia usado nenhum tipo de droga e que n&#xE3;o havia sido exposta a al&#xE9;rgenos ambientais. Disse tamb&#xE9;m que n&#xE3;o estava recebendo nem quimioterapia nem radioterapia. Todos os testes sorol&#xF3;gicos foram negativos, &#xE0; exce&#xE7;&#xE3;o do teste de autoanticorpos antiendom&#xED;sio. O exame f&#xED;sico mostrou que, ao longo de um per&#xED;odo de seis meses, a paciente perdera peso (5 kg) e massa muscular. Houve tamb&#xE9;m uma redu&#xE7;&#xE3;o da satura&#xE7;&#xE3;o de oxig&#xEA;nio (SaO<sub>2</sub> de 81% em ar ambiente). A ausculta&#xE7;&#xE3;o revelou murm&#xFA;rio vesicular reduzido e estertores bilaterais leves nos campos pulmonares superiores. A frequ&#xEA;ncia e o ritmo card&#xED;aco estavam normais. Suas extremidades tamb&#xE9;m estavam normais, sem baqueteamento digital. Os testes de fun&#xE7;&#xE3;o pulmonar revelaram CVF normal (96%) e VEF<sub>1</sub> normal (91%), embora a DLCO estivesse reduzida (61%). A radiografia de t&#xF3;rax inicial (n&#xE3;o mostrada) revelou opacidades irregulares pronunciadas na regi&#xE3;o subpleural dos campos superiores, com leve retra&#xE7;&#xE3;o hilar superior. Realizou-se fibrobroncoscopia com LBA, e verificou-se que os neutr&#xF3;filos correspondiam a 72% das c&#xE9;lulas inflamat&#xF3;rias (valor normal: 1-2%). Os resultados dos testes microbiol&#xF3;gicos foram negativos. Para elucidar os achados da radiografia de t&#xF3;rax e da LBA, realizou-se TCAR de t&#xF3;rax. A TCAR mostrou focos perif&#xE9;ricos de consolida&#xE7;&#xE3;o pulmonar, com distor&#xE7;&#xE3;o e espessamento pleuroparenquimatoso irregular, mais evidente nas regi&#xF5;es subpleurais dos lobos superiores, com bronquiolectasias, leve espessamento dos septos interlobulares e (em casos raros) altera&#xE7;&#xF5;es subpleurais microc&#xED;sticas (<xref ref-type="fig" rid="f1">Figura 1</xref>A). Imagens dos campos pulmonares inferiores (lobo m&#xE9;dio e l&#xED;ngula) revelaram muito menos altera&#xE7;&#xF5;es fibr&#xF3;ticas, sem distor&#xE7;&#xE3;o ou nenhuma outra doen&#xE7;a intersticial nos segmentos apicais e basais dos lobos inferiores (<xref ref-type="fig" rid="f1">Figuras 1B e 1C</xref>, respectivamente). Tais achados de TCAR s&#xE3;o um dilema diagn&#xF3;stico para o radiologista, que deve fazer o diagn&#xF3;stico diferencial entre FEPPI, sarcoidose e (embora menos prov&#xE1;vel) pneumonia de hipersensibilidade cr&#xF4;nica. Portanto, realizou-se tamb&#xE9;m uma bi&#xF3;psia pleuroparenquimatosa por congela&#xE7;&#xE3;o nos lobos superiores. Os achados histopatol&#xF3;gicos da colora&#xE7;&#xE3;o de fibras el&#xE1;sticas revelaram distor&#xE7;&#xE3;o e espessamento pleural pronunciado, com evid&#xEA;ncias de tecido fibroelast&#xF3;tico denso na pleura e nas paredes alveolares, bem como focos fibrobl&#xE1;sticos esparsos perto da transi&#xE7;&#xE3;o do pulm&#xE3;o para a pleura (<xref ref-type="fig" rid="f1">Figura 1</xref>D). Com base nos dados cl&#xED;nicos e radiol&#xF3;gicos, fez-se o diagn&#xF3;stico de FEPPI. Em suma, embora haja achados espec&#xED;ficos de TCAR que sugerem a presen&#xE7;a de FEPPI, a doen&#xE7;a continua a ser subdiagnosticada, provavelmente porque o conhecimento dessa entidade ainda seja escasso. Deve-se considerar o diagn&#xF3;stico de FEPPI em casos de fibrose pulmonar localizada predominantemente nos lobos superiores. O diagn&#xF3;stico diferencial inclui pneumonia de hipersensibilidade avan&#xE7;ada, sarcoidose avan&#xE7;ada, DPI avan&#xE7;ada relacionada com tabagismo, asbestose, doen&#xE7;a do tecido conjuntivo, pneumonia causada por radia&#xE7;&#xE3;o e doen&#xE7;a pulmonar induzida por drogas. Portanto, deve-se ter em mente a possibilidade de FEPPI quando as evid&#xEA;ncias radiol&#xF3;gicas n&#xE3;o forem coerentes com outras DPI, mais bem definidas. Recomenda-se que se realize, na &#xE1;rea afetada, bi&#xF3;psia cir&#xFA;rgica (por meio de videotoracoscopia) ou, melhor ainda, bi&#xF3;psia por congela&#xE7;&#xE3;o. &#xC9; necess&#xE1;rio compreender melhor a etiologia, os fatores de risco, o progn&#xF3;stico e a terapia da FEPPI para trat&#xE1;-la no futuro. </p>
        <p>
<fig id="f1" orientation="portrait" position="float"><label>Figura 1.</label><caption><title>TCAR de t&#xF3;rax e histologia: A) TCAR mostrando espessamento subpleural pronunciado e consolida&#xE7;&#xF5;es irregulares (setas pretas), opacidades reticulares no par&#xEA;nquima pulmonar nos lobos superiores, altera&#xE7;&#xF5;es subpleurais microc&#xED;sticas (setas brancas) e bronquiolectasias; B) TCAR mostrando altera&#xE7;&#xF5;es subpleurais fibr&#xF3;ticas esparsas nos segmentos apicais dos lobos pulmonares inferiores, mais pronunciadas &#xE0; direita; C) TCAR mostrando a quase aus&#xEA;ncia de altera&#xE7;&#xF5;es fibr&#xF3;ticas nos segmentos basais dos lobos pulmonares inferiores; D) corte histol&#xF3;gico mostrando tecido fibroelast&#xF3;tico subpleural denso com transi&#xE7;&#xE3;o abrupta de par&#xEA;nquima pulmonar patol&#xF3;gico para normal, contendo um foco fibrobl&#xE1;stico.</title></caption><graphic xlink:href="1806-3713-jbpneu-41-05-00478-gf01-pt"/></fig>
</p>
      </sec>
    </body>
  </sub-article>
</article>
</pmc-articleset>
